RDY

Symbol	last price	date	time	change	open	high	low	volume	P/E (ttm)	P/E (Forward)
RDY	29.78	9/2/2010	3:05pm	+0.59	29.41	29.85	29.31	330270

Summary

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It focuses on formulations, active pharmaceutical ingredients and intermediates, generic drugs, critical care products, biotechnology products, custom pharmaceutical services, and drug discovery. The company conducts research in the areas of cancer, cardiovascular disorders, bacterial infection, and metabolic disorders. It markets its products principally in India, Russia, the United States, the United Kingdom, Brazil, Germany, Spain, Italy, Australia, and South Africa. The company has an agreement with ClinTec International for the development an anti-cancer compound, DRF 1042. It also has a collaboration and license agreement with SCOLR Pharma, Inc. Dr. Reddy's Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.